Inflammation in variant angina: Is there any evidence?

Medical Hypotheses

Volumn 68, Issue 3, 2007, Pages 635-640

  Li, Jian Jun ^a   Nie, Shao Ping ^b   Xu, Bo ^a   Guo, Yuan Lin ^a   Gao, Zhan ^a   Zheng, Xin ^a  

^a FUWAI HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; C REACTIVE PROTEIN; FIBRINOGEN; GLYCERYL TRINITRATE; NITRIC OXIDE;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTICLE; ASTHMA; ATHEROSCLEROSIS; CD8+ T LYMPHOCYTE; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; DISEASE ASSOCIATION; EOSINOPHIL COUNT; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MORTALITY; NOSE POLYP; PRINZMETAL ANGINA PECTORIS; PRIORITY JOURNAL; RISK FACTOR; SINGLE DRUG DOSE; VARIANT ANGINA PECTORIS;

ANGINA PECTORIS, VARIANT; CORONARY VASOSPASM; HUMANS; INFLAMMATION;

ANGINA;

EID: 33845917124     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.05.068     Document Type: Article

References (35)

1. Murray C.J., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349 (1997) 1436-1442
2. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
3. Li J.J. Inflammation: an important mechanism for different clinical entities of coronary artery disease. Chin Med J 118 (2005) 1817-1826
4. Prinzmetal M., Kennamer R., Merliss R., et al. Angina pectoris-a variant form of angina pectoris. Am J Cardiol 27 (1959) 375-381
5. MacAlpin R.N. Relation of coronary arterial spasm to sites of organic stenosis. Am J Cardiol 46 (1980) 143-153
6. Miyao Y., Kugiyama K., Yawano H., et al. Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 36 (2000) 432-437
7. Suzuki H., Kawai S., Aizawa T., et al. Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. J Am Coll Cardiol 33 (1999) 198-205
8. Kugiyama K., Ohgushi M., Motoyama T., et al. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 30 (1997) 920-926
9. -786 → C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99 (1999) 2864-2870
10. Widlansky M.E., Gokce N., Keaney Jr. J.F., et al. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42 (2003) 1149-1160
11. Habbab M.A., Szwed S.A., and Haft J.I. Is coronary arterial spasm part of the aspirin-induced asthma syndrome?. Chest 90 (1986) 141-143
12. Nikolaidis L.A., Kounis N.G., and Gradman A.H. Allergic angina and allergic myocardial infarction: a new twist on an old syndrome. Can J Cardiol 18 (2002) 508-511
13. Takagi S., Goto Y., Hirose E., et al. Successful treatment of refractory vasospastic angina with corticosteroids: coronary arterial hyperactivity caused by local inflammation?. Circ J 68 (2004) 17-22
14. Caralis D.G., Deligonul U., Kern M.J., et al. Smoking is a risk factor for coronary spasm in young women. Circulation 85 (1992) 905-909
15. Auch-Schwelk W. Coronary spasm- a clinically relevant problem?. Herz 23 (1998) 106-115
16. Cannon III R.O. Angina pectoris with normal coronary angiogram. Cardiol Clin 9 (1991) 157-166
17. Bory M., Pierron F., Panagides D., et al. Coronary artery spasm in patients with normal or near normal coronary arteries. Eur Heart J 17 (1996) 1015-1021
18. Lewis J.R., Kisilevsky R., and Armstrong P.W. Prinzmetal's angina, normal coronary arteries and pericarditis. Can Med Assoc J 119 (1978) 36-39
19. Kovanen P.T., Kaartinen M., Paavone T., et al. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92 (1995) 1084-1088
20. Forman M.B., Oates J.A., Robertson D., et al. Increased adventitial mast cells in a patients with coronary spasm. N Engl J Med 313 (1985) 1138-1141
21. Marone G., Crescenzo G., Florio G., et al. Immunological modulation of human cardiac mast cells. Neurochem Res 24 (1999) 1195-1202
22. Kaartinen M., Pentilla A., Kovanen P., et al. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 90 (1994) 1669-1678
23. Cuculo A., Summaria F., Schiavino D., et al. Tryptase levels are elevated during spontaneous ischemic episode in unstable angina but not after the ergonovine test in variant angina. Cardiologia 43 (1998) 189-193
24. Terashima M., Akita H., Kanazawa K., et al. Circulating T-lymphocyte activation in patients with variant angina. Coron Artery Dis 13 (2002) 161-168
25. Hansson G.K., Holm J., and Jonasson L. Detection of activated T-lymphocytes in the human atherosclerotic plaque. Am J Pathol 135 (1989) 169-175
26. Zhou X., Stemme S., and Hansson G.K. Evidence for a local immune response in atherosclerosis. CD+40 T cells infiltrate lesions of apoprotein-E-deficient mice. Am J Pathol 149 (1996) 359-366
27. Hruban R.H., Kasper E.K., Gaudin P.B., et al. Severe lymphocytic endothelialitis associated with coronary artery spasm in a heart transplant recipient. J Heart Lung Transplant 11 (1992) 42-47
28. Hung M.J., Cherng W.J., Yang N.I., et al. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. Am J Cardiol 96 (2005) 1484-1490
29. Umemoto S., Suzuki N., Fujii K., et al. Eosinophil counts and plasma fibrinogen in patients with vasospastic angina pectoris. Am J Cardiol 85 (2000) 715-719
30. Laine P., Kaartinen M., Pentilla A., et al. Association between myocardial infarction and the mast cells in the adventitia of the infracted-related coronary artery. Circulation 99 (1999) 361-369
31. Rich M.W. Is vasospastic angina an inflammatory disease?. Am J Cardiol 66 (2005) 1612
32. Hung M.J., Kuo L.T., Cheng C.W., et al. Comparison of peripheral monocyte counts in patients with and without coronary spasm and without fixed coronary narrowing. Am J Cardiol 93 (2004) 620-624
33. Ogawa H., Sakamoto T., Nishiyama K., et al. Elevated levels of soluble intercellular adhesion molecule-1 in the coronary circulation of patients with coronary organic stenosis and spasm. Jpn Circ J 64 (2000) 170-176
34. Kugiyama K., Ota Y., Kawano H., et al. Increase in plasma levels of secretory type II phospholipase A (2) in patients with coronary spastic angina. Cardiovasc Res 47 (2000) 159-165
35. Hung M.J., Cherng W.J., Cheng C.W., et al. Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease. Am J Cardiol 95 (2005) 84-87